| Literature DB >> 15475145 |
Alvin Chua1, Colin Song, Andrea Chai, Lennard Chan, Kok Chai Tan.
Abstract
The skin banking programme was set-up in Singapore in 1998 to provide a ready source of allografts for patients with severe burns. The process and problems in establishing a local skin bank will be described together with a retrospective review of skin allograft recipients to determine the efficacy of the programme. For the skin bank set-up, pertinent issues related to legislation, methods, logistics, quality assurance and donation rate are discussed. In this retrospective review, a comparison between patients who had early complete excision with skin allograft transplantation and those who received conventional staged excision and coverage, was analysed in terms of clinical profile and outcome using statistical methods. The former group presented a significant reduction of mortality rate and hospital stay by 29% and 10 days, respectively. The establishment of the skin bank has helped in the management of severe burn patients by facilitating early excision and allografting. In a Burn Centre, therefore, it is essential to have an ample supply of skin allograft for burn victims in readiness for mass disaster situations.Entities:
Mesh:
Year: 2004 PMID: 15475145 PMCID: PMC7131307 DOI: 10.1016/j.burns.2004.03.016
Source DB: PubMed Journal: Burns ISSN: 0305-4179 Impact factor: 2.744
Additional donor exclusion criteria for skin donation
| Due to the outbreak of SARS, the following exclusion criteria have been added: |
|---|
| • Febrile patients (temperature >37.5 °C) anytime in the last 10 days where SARS cannot be excluded |
| • Patients stricken with pneumonia and lymphopenia |
| • Immunocompromised patients, i.e. ESRF, chronic steroid therapy, cancer patients on chemotherapy |
| • Patients with recent history of travel to SARS affected areas for emergency surgery, even if afebrile |
| • Patients with history of contact with SARS patients on home quarantine |
| • All suspect or probable SARS patients requiring emergency operations but were not fit for transfer to the SARS-designated hospital |
| • Patients from hotspots or isolation wards |
Profile of patients who received skin allografts between 1998 and September 2003
| With early excision | Control | ||
|---|---|---|---|
| 25 | 20 | – | |
| Age (year) | 31.7 ± 12.7 | 30.6 ± 11.2 | NS |
| Male/female | 16/9 | 12/8 | NS |
| TBSA (%) | 52.6 ± 16.6 | 56.0 ± 18.2 | NS |
| Range (%) | 31–85 | 33–88 | – |
| Full thickness; median (%) | 10.4 | 17.9 | NS |
| Smoke inhalation (Y/N) | 12/13 | 11/9 | NS |
NS: not significant.
Mann–Whitney U.
Chi-square.
Clinical results of patients who received skin allografts between 1998 and September 2003
| With early excision | Control | ||
|---|---|---|---|
| Days from burn injury to first operation | 1.7 ± 0.8 | 5.5 ± 3.8 | 0.001 |
| Mortality (Y/N) | 4/21 (16%) | 9/11 (45%) | 0.049 |
| Length of hospital stay | 48.3 ± 28.5 | 58.5 ± 12.4 | 0.044 |
Mann–Whitney U.
Chi-square.